1.
Mukri MNA, Kong W-Y, Mustafar R, Shaharir SS, Shah SA, Abdul Gafor AH, et al. Role of febuxostat in retarding progression of diabetic kidney disease with asymptomatic hyperuricemia: A 6-months open-label, randomized controlled trial. EXCLI J. [Internet]. 2018 Jun. 13 [cited 2024 Feb. 29];17:563-75. Available from: https://www.excli.de/index.php/excli/article/view/477